Table 1 Antibacterial efficacy of FcP₁-FcP₂₀ compounds against Xoo in vitro

Fc-CHO

55.25 ± 0.6

46.01 ± 1.2

y = 1.154x + 2.863

0.965

71.16 ± 0.10

1

57.21 ± 1.5

35.06 ± 0.6

y = 1.610x + 1.942

0.994

79.32 ± 3.05

2

49.76 ± 0.5

43.18 ± 2.2

y = 1.230x + 2.602

0.908

89.02 ± 4.32

FcP₂

98.1 ± 0.2

87.6 ± 0.6

y = 1.861x + 2.298

0.994

28.31 ± 0.76

FcP₃

100

100

y = 3.746x + 0.822

0.999

13.05 ± 0.03

FcP₄

97.1 ± 0.5

96.7 ± 0.6

y = 4.561x − 0.052

0.987

12.81 ± 0.06

FcP₅

100

100

y = 2.679x + 1.965

0.998

13.57 ± 0.45

FcP₆

98.1 ± 0.2

97.4 ± 0.2

y = 1.575x + 3.485

0.996

9.16 ± 0.02

FcP₇

100

86.3 ± 0.6

y = 2.820x + 1.339

0.984

19.67 ± 0.07

FcP₈

100

100

y = 1.055x + 4.051

0.995

7.94 ± 0.07

FcP₉

98.4 ± 0.3

97.8 ± 0.2

y = 5.529x − 2.606

0.982

23.75 ± 0.03

FcP₁₀

100

62.2 ± 0.3

y = 1.445x + 2.688

0.996

39.83 ± 0.50

FcP₁₁

98.1 ± 0.3

97.8 ± 0.1

y = 5.451x − 2.141

0.925

20.42 ± 0.04

FcP₁₂

100

100

y = 1.024x + 4.148

0.985

6.79 ± 0.03

FcP₁₃

98.1 ± 0.3

97.5 ± 0.3

y = 4.383x−0.281

0.930

16.03 ± 0.10

FcP₁₄

100

77.3 ± 0.1

y = 0.597x + 4.381

0.985

10.89 ± 0.09

FcP₁₅

100

100

y = 1.231x + 4.201

0.960

4.45 ± 0.04

FcP₁₅@β-CD

100

100

y = 1.239x + 4.262

0.996

3.94 ± 0.08

FcP₁₆

100

100

y = 0.966x + 4.230

0.975

6.27 ± 0.09

FcP₁₇

100

89.7 ± 0.2

y = 1.846x + 3.127

0.993

10.35 ± 0.10

FcP₁₈

100

32.2 ± 0.4

>50

FcP₁₉

100

58.2 ± 0.1

y = 1.578x + 2.481

0.959

39.48 ± 0.50

FcP₂₀

100

100

y = 0.976x + 4.057

0.999

9.21 ± 0.08

TC^b

62.3 ± 0.4

27.9 ± 0.7

y = 3.620x − 1.772

0.985

74.25 ± 0.45